Differential requirement for Rel/nuclear factor kB family members in natural killer T cell development

Journal of Experimental Medicine

Volumn 197, Issue 12, 2003, Pages 1613-1621

  Sivakumar, Vallabhapurapu ^a   Hammond, Kirsten J L ^b   Howells, Norma ^a   Pfeffer, Klaus ^c   Welh, Falk ^a,d  

^a Institute of Toxicology and Genetics   (Germany)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

Author keywords

Aly; NIK; NKT cells; RelB; Thymus

Indexed keywords

CD1D ANTIGEN; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NUCLEAR FACTOR KAPPA BETA INDUCING KINASE; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR REL; TRANSCRIPTION FACTOR RELB; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CELL MATURATION; CONTROLLED STUDY; DNA BINDING; HEMATOPOIETIC CELL; IMMUNE RESPONSE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOSENSITIVITY; REGULATORY MECHANISM; STROMA CELL; T LYMPHOCYTE SUBPOPULATION; THYMUS; TUMOR REJECTION;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; FIBROBLASTS; INTERLEUKIN-15; KILLER CELLS, NATURAL; LYMPHOTOXIN BETA RECEPTOR; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; NF-KAPPA B; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-REL; RECEPTORS, TUMOR NECROSIS FACTOR; SPLEEN; T-LYMPHOCYTE SUBSETS; THYMUS GLAND;

EID: 0038544245     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20022234     Document Type: Article

References (56)

1. Bendelac, A., M.N. Rivera, S.H. Park, and J.H. Roark. 1997. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 15:535-562.
2. Godfrey, D.I., K.J. Hammond, L.D. Poulton, M.J. Smyth, and A.G. Baxter. 2000. NKT cells: facts, functions and fallacies. Immunol. Today. 21:573-583.
3. MacDonald, H.R. 2002. Development and selection of NKT cells. Curr. Opin. Immunol. 14:250-254.
4. - T cells in mice and humans. J. Exp. Med. 180:1097-1106.
5. + T lymphocytes. Science. 268:863-865.
6. + T cells by CD1-expressing cortical thymocytes. J. Exp. Med. 182:2091-2096.
7. Mendiratta, S.K., W.D. Martin, S. Hong, A. Boesteanu, S. Joyce, and L. Van Kaer. 1997. CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity. 6:469-477.
8. Kawano, T., J. Cui, Y. Koezuka, I. Toura, Y. Kaneko, K. Motoki, H. Ueno, R. Nakagawa, H. Sato, E. Kondo, et al. 1997. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science. 278:1626-1629.
9. + NK T lymphocytes. J. Immunol. 161:3271-3281.
10. MacDonald, H.R. 2000. CD1d-glycolipid tetramers: a new tool to monitor natural killer T cells in health and disease. J. Exp. Med. 192:F15-F20.
11. Eberl, G., R. Lees, S.T. Smiley, M. Taniguchi, M.J. Grusby, and H.R. MacDonald. 1999. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells. J. Immunol. 162:6410-6419.
12. Hammond, K.J., S.B. Pelikan, N.Y. Crowe, E. Randle-Barrett, T. Nakayama, M. Taniguchi, M.J. Smyth, I.R. van Driel, R. Scollay, A.G. Baxter, and D.I. Godfrey. 1999. NKT cells are phenotypically and functionally diverse. Eur. J. Immunol. 29:3768-3781.
13. Robey, E., and B.J. Fowlkes. 1994. Selective events in T cell development. Annu. Rev. Immunol. 12:675-705.
14. Kronenberg, M., and L. Gapin. 2002. The unconventional lifestyle of NKT cells. Nat. Rev. Immunol. 2:557-568.
15. Gapin, L., J.L. Matsuda, C.D. Surh, and M. Kronenberg. 2001. NKT cells derive from double-positive thymocytes that are positively selected by CD1d. Nat. Immunol. 2:971-978.
16. Fu, Y.-X., and D.D. Chaplin. 1999. Development and maturation of secondary lymphoid tissues. Annu. Rev. Immunol. 17:399-433.
17. Miyawaki, S., Y. Nakamura, H. Suzuka, M. Koba, R. Yasumizu, S. Ikehara, and Y. Shibata. 1994. A new mutation, aly, that induces a generalized lack of lymph nodes accompanied by immunodeficiency in mice. Eur. J. Immunol. 24:429-434.
18. Matsumoto, M., K. Iwamasa, P.D. Rennert, T. Yamada, R. Suzuki, A. Matsushima, M. Okabe, S. Fujita, and M. Yokoyama. 1999. Involvement of distinct cellular compartments in the abnormal lymphoid organogenesis in lymphotoxin-α-deficient mice and alymphoplasia (aly) mice defined by the chimeric analysis. J. Immunol. 163:1584-1591.
19. Shinkura, R., K. Kitada, F. Matsuda, K. Tashiro, K. Ikuta, M. Suzuki, K. Kogishi, T. Serikawa, and T. Honjo. 1999. Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-κb-inducing kinase. Nat. Genet. 22:74-77.
20. Iizuka, K., D.D. Chaplin, Y. Wang, Q. Wu, L.E. Pegg, W.M. Yokoyama, and Y.-X. Fu. 1999. Requirement for membrane lymphotoxin in natural killer cell development. Proc. Natl. Acad. Sci. USA. 96:6336-6340.
21. Elewaut, D., L. Brossay, S.M. Santee, O.V. Naidenko, N. Burdin, H. De Winter, J. Matsuda, C.F. Ware, H. Cheroutre, and M. Kronenberg. 2000. Membrane lymphotoxin is required for the development of different subpopulations of NK T cells. J. Immunol. 165:671-679.
22. + T cell antigen receptor α/β thymocytes associated with intact thymic structure. Proc. Natl. Acad. Sci. USA. 94:2472-2477.
23. Karin, M., and A. Lin. 2002. NF-κB at the crossroads of life and death. Nat. Immunol. 3:221-227.
24. Karin, M., Y. Cao, F.R. Greten, and Z.W. Li. 2002. NF-κB in cancer: from innocent bystander to major culprit. Nat. Rev. Cancer. 2:301-310.
25. Li, Q., and I.M. Verma. 2002. NF-κB regulation in the immune system. Nat. Rev. Immunol. 2:725-734.
26. Pahl, H.L. 1999. Activators and target genes of Rel/NF-κB transcription factors. Oncogene. 18:6853-6866.
27. Karin, M., and Y. Ben-Neriah. 2000. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu. Rev. Immunol. 18:621-663.
28. Pomerantz, J.L., and D. Baltimore. 2002. Two pathways to NF-κB. Mol. Cell. 10:693-695.
29. Poljak, L., L. Carlson, K. Cunningham, M.H. Kosco-Vilbois, and U. Siebenlist. 1999. Distinct activities of p52/NF-κB required for proper secondary lymphoid organ microarchitecture: functions enhanced by Bcl-3. J. Immunol. 163:6581-6588.
30. Weih, D.S., Z.B. Yilmaz, and F. Weih. 2001. Essential role of RelB in germinal center and marginal zone formation and proper expression of homing chemokines. J. Immunol. 167:1909-1919.
31. Alcamo, E., N. Hacohen, L.C. Schulte, P.D. Rennert, R.O. Hynes, and D. Baltimore. 2002. Requirement for the NFκB family member RelA in the development of secondary lymphoid organs. J. Exp. Med. 195:233-244.
32. Gerondakis, S., M. Grossmann, Y. Nakamura, T. Pohl, and R. Grumont. 1999. Genetic approaches in mice to understand Rel/NF-κB and IκB function: transgenics and knockouts. Oncogene. 18:6888-6895.
33. Sha, W.C., H.-C. Liou, E.I. Tuomanen, and D. Baltimore. 1995. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell. 80:321-330.
34. Caamaño, J.H., C.A. Rizzo, S.K. Durham, D.S. Barton, C. Raventos-Suarez, C.M. Snapper, and R. Bravo. 1998. Nuclear factor (NF)-κB2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses. J. Exp. Med. 187:185-196.
35. Weih, F., D. Carrasco, S.K. Durham, D.S. Barton, C.A. Rizzo, R.-P. Ryseck, S.A. Lira, and R. Bravo. 1995. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family. Cell. 80:331-340.
36. Fütterer, A., K. Mink, A. Luz, M.H. Kosco-Vilbois, and K. Pfeffer. 1998. The lymphotoxin β receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues. Immunity. 9:59-70.
37. Pfeffer, K., T. Matsuyama, T.M. Kündig, A. Wakeham, K. Kishihara, A. Shahinian, K. Wiegmann, P.S. Ohashi, M. Krönke, and T.W. Mak. 1993. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell. 73:457-467.
38. Vallabhapurapu, S., R.-P. Ryseck, M. Malewicz, D.S. Weih, and F. Weih. 2001. Inhibition of NF-κB in T cells blocks lymphoproliferation and partially rescues autoimmune disease in gld/gld mice. Eur. J. Immunol. 31:2612-2622.
39. Matsuda, J.L., O.V. Naidenko, L. Gapin, T. Nakayama, M. Taniguchi, C.R. Wang, Y. Koezuka, and M. Kronenberg. 2000. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 192:741-754.
40. Hogan, B., R. Beddington, F. Costantini, and E. Lacy. 1994. Preparing mouse embryo fibroblasts. In Manipulating the Mouse Embryo. Cold Spring Harbor Laboratory Press, New York. 260-261.
41. Weih, F., D. Carrasco, and R. Bravo. 1994. Constitutive and inducible Rel/NF-κB activities in mouse thymus and spleen. Oncogene. 9:3289-3297.
42. Lantz, O., L.I. Sharara, F. Tilloy, A. Andersson, and J.P. DiSanto. 1997. Lineage relationships and differentiation of natural killer (NK) T cells: intrathymic selection and interleukin (IL)-4 production in the absence of NKR-P1 and Ly49 molecules. J. Exp. Med. 185:1395-1401.
43. + natural killer-T cell development. Eur. J. Immunol. 29:3313-3318.
44. Benlagha, K., T. Kyin, A. Beavis, L. Teyton, and A. Bendelac. 2002. A thymic precursor to the NK T cell lineage. Science. 296:553-555.
45. + CD1d-dependent precursor stage. J. Exp. Med. 195:835-844.
46. + T cells. J. Immunol. 164:2009-2015.
47. Burkly, L., C. Hession, L. Ogata, C. Reilly, L.A. Marconi, D. Olson, R. Tizard, R. Cate, and D. Lo. 1995. Expression of relB is required for the development of thymic medulla and dendritic cells. Nature. 373:531-536.
48. Xiao, G., E.W. Harhaj, and S.-C. Sun. 2001. NF-κB-inducing kinase regulates the processing of NF-κB2 p100. Mol. Cell. 7:401-409.
49. Yamada, T., T. Mitani, K. Yorita, D. Uchida, A. Matsushima, K. Iwamasa, S. Fujita, and M. Matsumoto. 2000. Abnormal immune function of hemopoietic cells from alymphoplasia (aly) mice, a natural strain with mutant NF-κB-inducing kinase. J. Immunol. 165:804-812.
50. Dobrzanski, P., R.-P. Ryseck, and R. Bravo. 1995. Specific inhibition of RelB/p52 transcriptional activity by the C-terminal domain of p100. Oncogene. 10:1003-1007.
51. Solan, N.J., H. Miyoshi, E.M. Carmona, G.D. Bren, and C.V. Paya. 2002. RelB cellular regulation and transcriptional activity ate are regulated by p100. J. Biol. Chem. 277:1405-1418.
52. Yilmaz, Z.B., D.S. Weih, V. Sivakumar, and F. Weih. 2003. RelB is required for Peyer's patch development: differential regulation of p52-RelB heterodimers by lymphotoxin and TNF. EMBO J. 22:121-130.
53. Paxian, S., H. Merkle, M. Riemann, M. Wilda, G. Adler, H. Hameister, S. Liptay, K. Pfeffer, and R.M. Schmid. 2002. Abnormal organogenesis of Peyer's patches in mice deficient for NF-κB1, NF-κB2, and Bcl-3. Gastroenterology. 122:1853-1868.
54. + cell development. J. Immunol. 159:5931-5935.
55. Matsuda, J.L., L. Gapin, S. Sidobre, W.C. Kieper, J.T. Tan, R. Ceredig, C.D. Surh, and M. Kronenberg. 2002. Homeostasis of Vα14i NKT cells. Nat. Immumol. 3:966-974.
56. Azimi, N., K. Brown, R.N. Bamford, Y. Tagaya, U. Siebenlist, and T.A. Waldmann. 1998. Human T cell lymphotropic virus type I Tax protein trans-activates interleukin 15 gene transcription through an NF-κB site. Proc. Natl. Acad. Sci. USA. 95:2452-2457.